Browsing: Lilly

If you had invested $5,000 in Eli Lilly (NYSE: LLY) five years ago, you’d be sitting pretty today. The stock has delivered a compound annual growth rate (CAGR) of 35.86% over this period (as of writing), turning $5,000 into about $23,143. This is much better than the S&P 500’s 12.82% CAGR since 2021, which would…

Veeva Systems (NYSE: VEEV) announced on August 11, 2026 that Eli Lilly and Company has committed to deploy Veeva Vault CRM globally. Vault CRM is part of the Vault CRM Suite, which Veeva describes as the technology foundation for agentic commercial, a new AI-enabled commercial model to help bring the right medicines to more patients.

This is a paid press release. Contact the press release distributor directly with any enquiries.